Journal of Clinical & Experimental Dermatology Research
Open Access

Ana Maria Buzaleh

Publications

• Case Report
  Identification of CYP3A5 and CYP2B6 Polymorphisms in Porphyria Cutanea Tarda Associated to Human Immunodeficiency Virus
  Author(s): Jimena V. Lavandera, Victoria E. Parera, Maria Victoria Rossetti, Alcira M. Del C. Batlle and Ana Maria Buzaleh Jimena V. Lavandera, Victoria E. Parera, Maria Victoria Rossetti, Alcira M. Del C. Batlle and Ana Maria Buzaleh
  
  To date, few or no data concerning the prevalence of polymorphisms in drug metabolism genes of antiretroviral drugs have been reported in the Argentinean population or in porphyric individuals worldwide. The purpose of the current investigation was to determine whether interindividual differences in cytochrome P450 3A5 (CYP3A) and 2B6 (CYP2B6) genes could influence the triggering of Porphyria Cutanea Tarda (PCT) in subjects with human immunodeficiency virus (HIV) after antiretroviral exposure. A total of 141 subjects, 60 control volunteers and 81 unrelated individuals with PCT were included in the study. In the porphyric group, 21 individuals were HIV positive. To evaluate the presence of the alleles CYP3A5*3, CYP3A5*6 and CYP2B6*6 a polymerase chain reaction (PCR) followed by restriction fragment length polymorphism (RFLP) analysis was performed. The frequencies of CYP3.. View More»
  DOI: 10.4172/2155-9554.S2-006

  Abstract PDF

Relevant Topics